MediPharm Labs Corp.
MediPharm Labs Corp. (LABS.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LABS.TO · as of Jun 9, 2026
Key Statistics
Explore MediPharm Labs Corp. Data
labs.to stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
labs.to competitorsLABS.TO
ADK.V
AVCN.TO
CWEB.TO
GLAB.CN
GWAY.CNStock Performance
Full HistoryAbout MediPharm Labs Corp.
MediPharm Labs Corp. operates as a pharmaceutical entity, specializing in the creation and global commercialization of premium, pharmaceutical-grade cannabis oils, concentrates, and sophisticated deri…
what is medipharm labs corp. · labs.to stock overview · medipharm labs corp. company profile · who is medipharm labs corp. ceo · labs.to TSX · medipharm labs corp. headquarters · medipharm labs corp. business segments
About Stock Overview & Key Data
MediPharm Labs Corp. (LABS.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Mar 4, 2019. As of the latest trading session, LABS.TO stock price is $0.07, with a market capitalization of $31.9M. The stock has returned -12.50% over the past 12 months and +7.69% year-to-date.
In fiscal year 2025, MediPharm Labs Corp. reported revenue of $45.1M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MediPharm Labs Corp. (LABS.TO) stock price is $0.07. The stock is traded on TSX under the ticker symbol LABS.TO. The 52-week range is $0.06 – $0.10.